{
  "Variants Include": [
    {
      "Gene": "SOD1",
      "variants": [
        {
          "HGVS": "NM_000434.4:c.1495A>G",
          "cDNA Change": {
            "transcript": "NM_000434.4",
            "ref": "A",
            "alt": "G",
            "position": "1495"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "G",
            "position": "505"
          },
          "Description in input context": "This variant introduces a glycine to aspartate substitution in the SOD1 protein."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Amyotrophic Lateral Sclerosis (ALS)",
    "MONDO": "MONDO:0003917"
  },
  "Experiment Method": [
    {
      "Assay Method": "Reverse Transcription Polymerase Chain Reaction (RT-PCR)",
      "Material used": {
        "Material Source": "Patient-Derived Material",
        "Material Name": "Fibroblasts from ALS patients",
        "Description": "Fibroblasts were cultured from skin biopsies obtained from ALS patients under informed consent."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000434.4:c.1495A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The variant NM_000434.4:c.1495A>G significantly decreased SOD1 mRNA levels compared to control fibroblasts."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Each experiment was performed with fibroblasts from three independent ALS patients."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in duplicate for qRT-PCR."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Fibroblasts from healthy donors were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No-template controls were included in the qRT-PCR reaction."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test was used to compare SOD1 mRNA levels between ALS and control fibroblasts."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "SOD1 mRNA expression within the range observed in fibroblasts from healthy donors.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "SOD1 mRNA levels less than 50% of those observed in fibroblasts from healthy donors.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}